Aprea Therapeutics, Inc. (APRE)
R&D Expenses
$2.46M
Quarterly · Period ending: · USD
APRE R&D Expenses
Latest reported$2.46Mperiod ending
Latest reported$2.46Mperiod ending
APRE Quarterly R&D Expenses ($2.31M → $2.46M)
Quarterly R&D Expenses
High-resolution chart · PNG
APRE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 2,462,042 | |
| 1,611,167 | |
| 1,008,839 | |
| 1,638,917 | |
| 1,912,213 | |
| 2,483,066 | |
| 2,359,086 | |
| 2,846,399 | |
| 2,557,679 | |
| 1,600,373 | |
| 2,045,688 | |
| 2,122,603 | |
| 2,202,657 | |
| 1,256,542 | |
| 531,406 | |
| 1,117,576 | |
| 82,831,793 | |
| 4,089,577 | |
| 4,462,154 | |
| 6,015,616 | |
| 6,654,257 | |
| 6,763,848 | |
| 9,328,079 | |
| 8,761,095 | |
| 10,694,029 | |
| 9,096,122 | |
| 8,041,993 | |
| 4,910,409 | |
| 4,319,826 | |
| 3,678,444 | |
| 4,394,921 | |
| 2,307,022 |